OverviewSuggest Edit

Eurofins Scientific is a life sciences company providing laboratory testing services. It offers food, environmental, pharmaceutical, and cosmetic product testing, as well as agroscience contract research organization (CRO) services. The company also provides testing and laboratory services for genomics, discovery pharmacology, forensics, contract development and manufacturing organization (CDMO), advanced material sciences, etc.
TypePublic
Founded1987
HQLuxembourg, LU
Websiteeurofins.com
Overall CultureC

Latest Updates

Employees (est.) (Dec 2020)44,741(+3%)
Job Openings3,558
Revenue (FY, 2020)€5.4 B(+20%)
Share Price (Apr 2021)€87.6
Cybersecurity ratingDMore

Key People/Management at Eurofins

Gilles G. Martin

Gilles G. Martin

Founder, Chairman & CEO
Christian Wurst

Christian Wurst

Chief Operating Officer, Food & Environment Testing
Yves-Loïc Martin

Yves-Loïc Martin

Executive Director
Mark Thys

Mark Thys

Chief Transformation Officer
Valérie Hanote

Valérie Hanote

Executive Director
Laurent Lebras

Laurent Lebras

Group Finance & Administration Director
Show more

Eurofins Office Locations

Eurofins has offices in Luxembourg, Alachua, Arvada, Austin and in 605 other locations
Luxembourg, LU (HQ)
23 Val Fleuri
Luxembourg, LU
10a Rue Henri M. Schnadt
Aix-en-Provence, FR
105 Avenue de Bredasque
Aix-en-Provence, FR
1 Rue Aude
Aix-en-Provence, FR
210 Avenue du Grand Vallat
Aix-en-Provence, FR
505 Rue Louis Berton
Show all (785)

Eurofins Financials and Metrics

Eurofins Revenue

Embed Graph
View revenue for all periods
Eurofins's revenue was reported to be €5.44 b in FY, 2020 which is a 19.2% increase from the previous period.
EUR

Revenue (FY, 2020)

5.4b

Revenue growth (FY, 2019 - FY, 2020), %

19.2%

Gross profit (FY, 2020)

3.7b

Gross profit margin (FY, 2020), %

67.9%

Net income (FY, 2020)

540.5m

EBITDA (FY, 2020)

1.4b

EBIT (FY, 2020)

800.3m

Market capitalization (20-Apr-2021)

16.7b

Closing stock price (20-Apr-2021)

87.6

Cash (31-Dec-2020)

912.4m

EV

19.0b
Eurofins's current market capitalization is €16.7 b.
Annual
EURFY, 2018FY, 2019FY, 2020

Revenue

3.8b4.6b5.4b

Revenue growth, %

27%21%19%

Cost of goods sold

1.3b1.5b1.7b

Gross profit

2.4b3.1b3.7b
Half Year
EURH1, 2018H1, 2019H1, 2020

Revenue

1.7b2.2b2.3b

Depreciation and amortization

104.9m182.2m199.7m

EBITDA

287.8m370.9m458.6m

EBITDA margin, %

17%17%20%
Annual
EURFY, 2018FY, 2019FY, 2020

Cash

506.2m297.0m912.4m

Accounts Receivable

864.9m853.8m993.4m

Prepaid Expenses

42.7m42.5m59.6m

Inventories

66.4m79.3m157.0m
Half Year
EURH1, 2018H1, 2019H1, 2020

Cash

559.0m304.6m615.4m

Accounts Receivable

730.7m913.7m

Inventories

53.2m74.4m123.9m

Current Assets

1.6b1.6b1.9b
Annual
EURFY, 2018FY, 2019FY, 2020

Depreciation and Amortization

223.7m395.9m426.0m

Inventories

(14.6m)(12.9m)(77.7m)

Accounts Payable

71.1m36.8m132.2m

Cash From Operating Activities

543.9m677.9m1.2b
Half Year
EURH1, 2018H1, 2019H1, 2020

Depreciation and Amortization

104.9m182.2m199.7m

Cash From Operating Activities

217.8m232.0m445.0m

Purchases of PP&E

(151.8m)(141.0m)(113.0m)

Cash From Investing Activities

(383.8m)(223.0m)(205.3m)
EURH1, 2018

Revenue/Employee

50.5k

Debt/Equity

0.9 x

Debt/Assets

0.4 x

Financial Leverage

2.3 x
Show all financial metrics

Eurofins Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Business Sites

1.3 k1.4 k1.4 k

Countries

44475050

Facility Space, sq. m

1.25 m1.35 m1.4 m

Laboratories

400800800800
Show all operating metrics

Eurofins Acquisitions / Subsidiaries

Company NameDateDeal Size
Lab SolutionJuly 11, 2019
Transplant Genomics Inc.June 25, 2019
Chemtest LimitedApril 11, 2019
EnvironeX GroupOctober 31, 2018
TestAmerica LaboratoriesOctober 31, 2018
Laboratoire DermscanOctober 29, 2018
Clinical Research LaboratoriesSeptember 04, 2018
Nanolab TechnologiesAugust 02, 2018
Covance Food SolutionsAugust 01, 2018
Laboratorios EcosurJuly 27, 2018
Show more

Eurofins Revenue Breakdown

Embed Graph

Eurofins revenue breakdown by business segment: 5.9% from Study-Based Business, 88.0% from Sample-Based usiness and 6.1% from Other

Eurofins revenue breakdown by geographic segment: 57.8% from Europe, 34.7% from North America and 7.5% from Rest of the World

Human Capital Metrics

Embed Graph
Show all human capital metrics

Eurofins Cybersecurity Score

Cybersecurity ratingPremium dataset

D

64/100

SecurityScorecard logo

Eurofins Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Eurofins Online and Social Media Presence

Embed Graph

Eurofins Company Culture

  • Overall Culture

    C

    65/100

  • CEO Rating

    C

    66/100

  • Compensation

    D+

    56/100

  • Diversity

    A+

    84/100

Learn more on Comparably

Eurofins News and Updates

IATA and Eurofins Partner to Boost Travel with Testing

The International Air Transport Association (IATA) announced an agreement with Eurofins to incorporate its worldwide COVID-19 testing network into IATA Travel Pass. Eurofins is a leader in bio-analytical testing with 800 laboratories across 50 countries. As part of the partnership, Eurofins’ dedicat…

Poultry giant Moy Park announces senior appointments

And last week, Eurofins food and Water Testing UK appointed former 2 Sisters business unit director Mark Carnaghan to the role of managing director.

Vicky Phelan celebrates ‘goal’ of reaching son’s 10th birthday as Lynsey Bennett provides Mexico cancer treatment update

Bennett, 32, sued the HSE, Dublin testing laboratory Eurofins Biomnis Ireland Ltd and US lab Quest Diagnostics Inc over the alleged misinterpretation of cervical smear slides.

Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise

Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing announces the acquisition of Beacon Discovery, a preeminent drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research. Beacon Discovery joins Eurofins Di…

Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world

DUBLIN, Feb. 2, 2021 /PRNewswire/ -- Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to rapidly identify the...

Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world

Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to rapidly identify the presence of these variants.
Show more

Eurofins Frequently Asked Questions

  • When was Eurofins founded?

    Eurofins was founded in 1987.

  • Who are Eurofins key executives?

    Eurofins's key executives are Gilles G. Martin, Christian Wurst and Yves-Loïc Martin.

  • How many employees does Eurofins have?

    Eurofins has 44,741 employees.

  • What is Eurofins revenue?

    Latest Eurofins annual revenue is €5.4 b.

  • What is Eurofins revenue per employee?

    Latest Eurofins revenue per employee is €121.6 k.

  • Who are Eurofins competitors?

    Competitors of Eurofins include IQVIA, Catalent and Evotec.

  • Where is Eurofins headquarters?

    Eurofins headquarters is located at 23 Val Fleuri, Luxembourg.

  • Where are Eurofins offices?

    Eurofins has offices in Luxembourg, Alachua, Arvada, Austin and in 605 other locations.

  • How many offices does Eurofins have?

    Eurofins has 785 offices.